CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 217 enrolled
Drug / intervention
ePrEPother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03729570
NCT03729570N/ACompleted

Testing an Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System to Promote PrEP Among Adolescent Men Who Have Sex With Men (MSM) in Rural and Small Town Areas

Emory University·interventional·Posted Nov 2, 2018·Updated Oct 18, 2024

In Brief

A clinical study evaluating ePrEP for Pre-exposure Prophylaxis. Completed, enrolled 217 participants across 4 sites.

Detailed Summary

The premise for the study is that a tailored approach for rural young men who have sex with men (YMSM), addressing known barriers of transportation, access to providers, and privacy, is most likely to yield high levels of Pre-exposure Prophylaxis (PrEP) initiation and persistence in care.

Study Details

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 2, 2018
Enrollment StartMay 28, 2019
Primary CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.7 years ago

Interventions

ePrEPother

Participants will have a baseline teleconsultation with a site study clinician who will be responsible for prescribing PrEP as indicated. They will be offered a 1-month check-in and telemedicine consultations at 3, 6, 9 and 12 months. Participants will complete home specimen collection for laboratory tests for each consultation. The virtual study visit consists of surveys, specimen collection, and a telemedicine consultation.